Search - tctmd.com

Displaying 81 - 100 of 131

Sort: Relevancy | Date

News Conference News AHA 2018

Complications Following TAVR Are Going Down, US Data Show

Yael L. Maxwell

November 20, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

News Daily News

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Yael L. Maxwell

September 17, 2018

News Daily News

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Yael L. Maxwell

April 25, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Daily News

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

L.A. McKeown

February 07, 2018

News Daily News

Sex Differences Diminish With Third-Generation TAVR Device

L.A. McKeown

January 05, 2018

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Presentation TCT 2017

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

Presenter: Reginald I. Low, Michael J. Rinaldi, Mani Arsalan, MD

October 31, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

Advertisement

Complications Following TAVR Are Going Down, US Data Show

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

Sex Differences Diminish With Third-Generation TAVR Device

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Isolated Tricuspid Valve Surgery Remains Rare and Risky

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content